Results 181 to 190 of about 74,566 (254)

Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.

Cancer Treatment and Research Communications, 2022
J. Bridgewater, X. Jiao, M. Parimi, C. Flach, Jeran K. Stratford, A. Kamburov, A. Schmitz, J. Zong, J. Reeves, K. Keating, A. Bruno, M. Fellous, M. B. Pereira, L. Bazhenova   +13 more
semanticscholar   +1 more source

The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia. [PDF]

Int J Mol Sci, 2021
Rodrigues-Amorim D, Iglesias-Martínez-Almeida M, Rivera-Baltanás T, Fernández-Palleiro P, Freiría-Martínez L, Rodríguez-Jamardo C, Comís-Tuche M, Vallejo-Curto MDC, Álvarez-Ariza M, López-García M, de Las Heras E, García-Caballero A, Olivares JM, Spuch C.   +13 more
europepmc   +1 more source

Ischemic postconditioning ameliorates diabetic cerebral ischemia via activating the brain-derived neurotrophic factor-tropomyosin receptor kinase B-hypoxia-inducible factor 1α-Bcl-2/adenovirus E1B 19-kDa-interacting protein 3 pathway to induce microglial mitophagy and suppress A1 astrocyte-mediated neuroinflammation. [PDF]

Front Endocrinol (Lausanne)
Zhao L, Han Y, Wang Y, Ke T, Huang S.
europepmc   +1 more source

Bioenergetics of protein transport into mitochondria [PDF]

, 1988
Döhren, H. von, Jaenicke, L., Kleinkauf, Horst, Neupert, Walter, Pfanner, Nikolaus   +4 more
core  

Postsurgical tactile-evoked pain: a role for brain-derived neurotrophic factor-tropomyosin receptor kinase B-dependent novel tactile corpuscles. [PDF]

Pain Rep
Wilson K, Sze Y, Regan A, Zhu C, Mazur K, Velichkova AN, Torsney C.   +6 more
europepmc   +1 more source

Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology. [PDF]

JCO Precis Oncol
Vince CSC, Brassesco MS, Mançano BM, Gregianin LJ, Carbone EK, do Amaral E Castro A, Dwan VSY, Menezes da Silva RZ, Mariano CS, da Mata JF, Silva MO, Caran EMM, Macedo CD, Alves da Costa G, Esteves TC, Silva LN, Ferman SE, Martins FD, Cristófani LM, Odone-Filho V, Silva MM, Reis RM, Pianovski MAD, Campregher PV, Kunii MS, de Sá Rodrigues KE, Carvalho Filho NP, Valera ET, Brazilian Committee of Precision Medicine in Pediatric Oncology (BC-PMPO)—the Brazilian Society of Pediatric Oncology (SOBOPE).   +28 more
europepmc   +1 more source

Retraction: Yizhi Qingxin formula extract ameliorates cognitive decline in aged rats via the brain-derived neurotrophic factor/tropomyosin receptor kinase B pathway. [PDF]

Front Pharmacol
Frontiers Editorial Office.
europepmc   +1 more source

Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis. [PDF]

Cancers (Basel), 2020
Italiano A, Nanda S, Briggs A, Garcia-Foncillas J, Lassen U, Vassal G, Kummar S, van Tilburg CM, Hong DS, Laetsch TW, Keating K, Reeves JA, Fellous M, Childs BH, Drilon A, Hyman DM.   +15 more
europepmc   +1 more source

Synthesis, anticancer evaluation, molecular docking and ADME study of novel pyrido[4',3':3,4]pyrazolo[1,5-a]pyrimidines as potential tropomyosin receptor kinase A (TrKA) inhibitors. [PDF]

BMC Chem
Metwally NH, Deeb EA, Hasani IW.
europepmc   +1 more source

Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? [PDF]

, 2015
Cristina Cătană, George A. Calin, Ioana Neagoe   +2 more
core   +1 more source